CDK9 (cyclin dependent kinase 9)

2006-10-01  

Identity

HGNC
LOCATION
9q34.11
LOCUSID
ALIAS
C-2k,CDC2L4,CTK1,PITALRE,TAK
FUSION GENES

Other Information

Locus ID:

NCBI: 1025
MIM: 603251
HGNC: 1780
Ensembl: ENSG00000136807

Variants:

dbSNP: 1025
ClinVar: 1025
TCGA: ENSG00000136807
COSMIC: CDK9

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000136807ENST00000373264P50750
ENSG00000136807ENST00000373264A0A024R880
ENSG00000136807ENST00000421939X6RE90

Expression (GTEx)

0
50
100
150
200

Pathways

PathwaySourceExternal ID
Transcriptional misregulation in cancerKEGGko05202
Transcriptional misregulation in cancerKEGGhsa05202
DiseaseREACTOMER-HSA-1643685
Infectious diseaseREACTOMER-HSA-5663205
HIV InfectionREACTOMER-HSA-162906
HIV Life CycleREACTOMER-HSA-162587
Late Phase of HIV Life CycleREACTOMER-HSA-162599
Transcription of the HIV genomeREACTOMER-HSA-167172
HIV Transcription ElongationREACTOMER-HSA-167169
Tat-mediated elongation of the HIV-1 transcriptREACTOMER-HSA-167246
Formation of HIV-1 elongation complex containing HIV-1 TatREACTOMER-HSA-167200
HIV elongation arrest and recoveryREACTOMER-HSA-167287
Formation of HIV elongation complex in the absence of HIV TatREACTOMER-HSA-167152
Pausing and recovery of HIV elongationREACTOMER-HSA-167290
Tat-mediated HIV elongation arrest and recoveryREACTOMER-HSA-167243
Pausing and recovery of Tat-mediated HIV elongationREACTOMER-HSA-167238
Host Interactions of HIV factorsREACTOMER-HSA-162909
Interactions of Tat with host cellular proteinsREACTOMER-HSA-176034
Signal TransductionREACTOMER-HSA-162582
Signaling by TGF-beta Receptor ComplexREACTOMER-HSA-170834
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimerREACTOMER-HSA-2173793
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcriptionREACTOMER-HSA-2173796
Gene ExpressionREACTOMER-HSA-74160
Generic Transcription PathwayREACTOMER-HSA-212436
Transcriptional Regulation by TP53REACTOMER-HSA-3700989
RNA Polymerase II TranscriptionREACTOMER-HSA-73857
RNA Polymerase II Pre-transcription EventsREACTOMER-HSA-674695
RNA Polymerase II Transcription ElongationREACTOMER-HSA-75955
Formation of RNA Pol II elongation complexREACTOMER-HSA-112382
TP53 Regulates Transcription of DNA Repair GenesREACTOMER-HSA-6796648
RNA polymerase II transcribes snRNA genesREACTOMER-HSA-6807505

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
375517452024CDK7 and CDK9 inhibition interferes with transcription, translation, and stemness, and induces cytotoxicity in GBM irrespective of temozolomide sensitivity.2
383018872024Actin associates with actively elongating genes and binds directly to the Cdk9 subunit of P-TEFb.0
383158422024RNF20 contributes to epigenetic immunosuppression through CDK9-dependent LSD1 stabilization.1
386610322024CDK9 inhibition activates innate immune response through viral mimicry.1
388487772024Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma.0
375517452024CDK7 and CDK9 inhibition interferes with transcription, translation, and stemness, and induces cytotoxicity in GBM irrespective of temozolomide sensitivity.2
383018872024Actin associates with actively elongating genes and binds directly to the Cdk9 subunit of P-TEFb.0
383158422024RNF20 contributes to epigenetic immunosuppression through CDK9-dependent LSD1 stabilization.1
386610322024CDK9 inhibition activates innate immune response through viral mimicry.1
388487772024Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma.0
368968912023Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer.5
370605072023Selective CDK9 knockdown sensitizes TRAIL response by suppression of antiapoptotic factors and NF-kappaB pathway.1
375640022023Degradation of CDK9 by Ubiquitin E3 Ligase STUB1 Regulates P-TEFb Level and Its Functions for Global Target Gene Expression within Mammalian Cells.0
368968912023Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer.5
370605072023Selective CDK9 knockdown sensitizes TRAIL response by suppression of antiapoptotic factors and NF-kappaB pathway.1

Citation

Dessen P

CDK9 (cyclin dependent kinase 9)

Atlas Genet Cytogenet Oncol Haematol. 2006-10-01

Online version: http://atlasgeneticsoncology.org/gene/43202/teaching-explorer/deep-insight-explorer/js/lib/jquery-3.5.1.min.js